UNDERSTANDING MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system (CNS) that disrupts the flow of information within the brain, and between the brain and body. According to the National Multiple Sclerosis Society, the disease is thought to affect more than 2.3 million people worldwide, that number may be a significant under estimate since MS is not a reportable disease and no centralized reporting system exists at this time. Also, MS can be difficult to diagnose. Since there is no single test for MS, the diagnosis can be missed, delayed or even incorrect.
In MS, the immune system malfunctions destroying the myelin which is the fatty substance that coats and protects nerve fibers in the brain and spinal cord. Often times, the myelin is compared to the insulation coating that surrounds electrical wires. When the surrounding protective myelin is damaged and the nerve fibers are exposed, the messages traveling along the nerve become slow or potentially blocked. In some cases, the nerve becomes damaged.
CURRENT TREATMENT OPTIONS FOR MULTIPLE SCLEROSIS
Currently, Multiple Sclerosis medications only offer treatment and therapy for the symptoms of the disease. Unfortunately, there is no standard medical treatment for the two main causes that contribute to the progression of the disease which include the body’s autoimmune attack against the central nervous system, and the resulting demyelination. Majority of MS drugs focus on addressing symptoms for only one of the primary causes of progression.
MULTIPLE SCLEROSIS STEM CELL RESEARCH STUDIES
- Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis
- Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
- Therapeutic effects of adipose derived mesenchymal stem cells on remyelination process in inflammatory demyelinating diseases